Group items tagged

The Royal College of GPs (RCGP) has warned that patients in deprived areas could face even greater difficulty accessing GP services if funding for the Targeted Enhanced Recruitment Scheme (TERS) is withdrawn. In a letter to NHS England, the College is calling for confirmation that TERS will be extended for 2025/26 and beyond. The scheme, launched in 2016, was designed to attract GP trainees to economically disadvantaged areas, where healthcare provision has historically been inadequate. TERS offers a one-off payment of £20,000 to GP trainees who commit to working in hard-to-recruit-to locations. Over the years, the scheme has successfully recruited over 2,000 GPs. However, with funding for 2025/26 yet to be confirmed, the RCGP is worried that it could be cut from April. The College has expressed concern that discontinuing the scheme could "make it even more difficult to recruit GPs to work in deprived and under-doctored areas where patients are already significantly disadvantaged compared to those in more affluent areas of the country."

The King's New Year Honours List 2025 has been announced, recognising unsung heroes who have made outstanding contributions to their communities across the UK. Over 1,200 individuals were honoured this year across various sectors, including healthcare, academia, sports, and voluntary service. Michelle Riddalls, CEO of PAGB - the Consumer Healthcare Association, has been awarded an OBE (Officer of the Order of the British Empire) for her exceptional work in advocating for the over-the-counter (OTC) medicines sector. She played a vital role during Brexit negotiations, ensuring continued access to OTC medicines in Northern Ireland and supporting self-care initiatives across the UK. Riddalls has provided oral evidence numerous times to the House of Lords Select Committee on the NI Protocol Bill and actively engaged with the Medicines and Healthcare products Regulatory Agency (MHRA) during the rollout of the Windsor Framework.

The King's New Year Honours List 2025 has been announced, recognising unsung heroes who have made outstanding contributions to their communities across the UK. Over 1,200 individuals were honoured this year across various sectors, including healthcare, academia, sports, and voluntary service. Two pharmacists were honoured for their exceptional contributions to public health: Laura Catherine McIver, former chief pharmacist at Healthcare Improvement Scotland, was awarded a CBE (Commander of the Order of the British Empire) for her services to the pharmacy profession and patient safety. Alan Malcom Kurtz, proprietor and manager of Fishers Chemist in South Norwood, London, received a Medal of the Order of the British Empire (BEM) for services to community pharmacy. Prime Minister Sir Keir Starmer thanked the recipients, saying: "Each and every day, ordinary people go out and do extraordinary things for their communities.

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed. Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines. Kinnock stated that consultation with Community Pharmacy England (CPE) for the 2025/26 Community Pharmacy Contractual Framework (CPCF) has started and will include "reviewing the allowance for medicine margin as part of funding, and any further changes to the reimbursement arrangements." However, he clarified that there are currently no plans to review the reimbursement system for general practices (GPs) dispensing medicines. Kinnock said: "Dispensing practices receive a dispensing fee, approximately £2.00 to £2.30 per item, which is intended to cover dispensing costs. "This fee is calculated based on forecasted volumes of prescriptions to be dispensed and the size of the funding envelope, according to a methodology agreed by the Department, the General Practitioners Committee (GPC), NHS Employers, and the Welsh Government."

The Company Chemists' Association (CCA) has raised concern that pharmacies may face challenges in providing placements to pharmacy students graduating in 2025 due to shortages of designated prescribing practitioners (DPPs). From the academic year 2025/26, all pharmacy students will be required to complete 90 hours of training with designated prescribing practitioners prior to their registration. However, the CCA has raised doubts regarding the availability of these healthcare professionals to provide such training. The association said: "We are concerned that pharmacies will be unable to secure DPPs. This will result in a significant reduction in the number of Foundation Pharmacist placements available within the community pharmacy sector. Consequently, a significant number of graduates leaving university next year will, unfortunately, struggle to find employment in their chosen career." As per the CCA, they have repeatedly raised their concerns with NHS England and cautioned them about the potential consequences arising from the lack of DPPs.

Pharmacies in England will soon be allowed to dispense up to 10 per cent more or less than the quantity prescribed for NHS prescriptions, thanks to the introduction of new original pack dispensing (OPD) rules. These changes are part of regulatory amendments laid on Tuesday, 3 September, and will come into effect over the coming months. The amendments are being made to the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2024 (PLPS). Starting 1 January 2025, pharmacies will have the option to adjust the prescribed quantity by up to 10 per cent for NHS prescriptions so medicines can be supplied in their original manufacturer's pack. Earlier in October 2023, changes to the Human Medicines Regulations (HMRs) permitted pharmacies to dispense up to 10 per cent more or less than the prescribed quantity for private prescriptions of Prescription Only Medicines (POMs).

RPS Wales will once again spearhead the development of new three-year goals to help pharmacy in Wales advance toward its 2030 vision as outlined in Pharmacy: Delivering a Healthier Wales (PDaHW). Elen Jones, Director of RPS Wales, and Jonathan Simms, Chair of the Welsh Pharmaceutical Committee, announced during the recent RPS Wales Conference. Jones said: "I'd like to thank the Welsh Government and the Welsh Pharmaceutical Committee for once again entrusting RPS to take this work forward." This iteration of PDaHW builds on the original 10-year plan, published in 2019, and the two series of stepping stone goals established from 2019-2022 and 2022-2025. Work on the new three-year goals will begin in early 2025.

Pharmacy owners will be given additional time to claim for the provision of four services if IT issues, outside their control, prevent timely submissions. Effective February 2025, this provision applies to Hypertension Case-Finding, Pharmacy Contraception Service, Pharmacy First, and Smoking Cessation Services. Currently, claims must be submitted via the Manage Your Service (MYS) portal by the 5th of the following month, with late claims accepted only within three months of the actual submission date. Under the new rule, pharmacy owners will have an additional twelve months (from the date by which the claim should have been submitted) to claim payment if they can provide evidence of an IT issue beyond their control that delayed the claim submission. This new provision will be included in Part VIC of the February 2025 Drug Tariff, which will also have a clarification about de-registration from the four advanced services. The clarification will state that pharmacy owners who de-register from providing one of these services cannot re-register for four months after their 30-day notice period ends.

Pharmacists are being notified of a limited supply of hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules, with stock expected to be exhausted by late March 2025. The Department of Health and Social Care (DHSC) has issued a medicine supply notification, indicating that resupply is not anticipated until May 2026. NHS provider Trust pharmacy procurement and clinical teams are advised to collaborate in reserving existing stock of the solution for injection, specifically for patients who require hydrocortisone sodium phosphate during an adrenal crisis. The DHSC added that this stock has an expiry date of June 2025. Hydrocortisone is used to replace steroids in individuals with adrenal insufficiency, such as those with Congenital Adrenal Hyperplasia (CAH) or Addison's disease, where the adrenal glands produce insufficient natural steroids. People with adrenal insufficiency or anyone who is "steroid-dependent" require a hydrocortisone emergency injection kit to prevent an acute adrenal crisis, which can be life-threatening.

The General Pharmaceutical Council is in the process of appointing five new council members within the next two years, coinciding with the conclusion of the current members' terms. The regulator aims to recruit five individuals from diverse professional and personal backgrounds for its governing council, the GPhC has said. "We are seeking three members to join us in April 2024 and two in April 2025," said GPhC in its job advertisement brief. "For the 2024 intake, two of the new council members must be lay members of the public, while one must be a Saxton . Moreover, at least one out of the three must primarily reside or work wholly or mostly in Wales. As for the new members commencing in 2025, one must be a lay member, and the other must be a registrant member." The members will be initially appointed for a three-year term, with the option to extend their position for a maximum of eight years, GPhC added. The council, which serves as the regulator's governing body, currently comprises 14 members. Half of the council consists of lay members, who bolster public confidence and infuse novel viewpoints into the GPhC, as highlighted by the regulator. "This council will play a pivotal role in shaping the regulatory body's future strategic goals," the regulator added. "These members must contribute positively to patients and society, ensuring the benefits of secure and efficient pharmacy care."

The Royal Pharmaceutical Society (RPS) has published Pharmacy: Delivering a Healthier Wales that outlines a plan focusing on what can be achieved by end of 2025. The society has urged people to share their views by responding to the consultation on four key themes which were already set out in Pharmacy: Delivering a Healthier Wales -enhancing patient experience; developing the pharmacy workforce; seamless pharmaceutical care; and harnessing innovation and technology. "We want to hear from as many of you as possible. It is important that the aims for pharmacy over the next three years are right. So please take a look at the draft 2025 goals, the proposed activity and measures and complete our consultation response form by 11 September," said RPS. "We have been proud to continue to manage this important ambition for Wales, working on behalf of the Welsh Pharmaceutical Committee and with colleagues from all over Wales. Over 300 of you have already contributed to our face to face and virtual engagement sessions we held over the past three months and we thank you for your valuable input.

The National Pharmacy Association (NPA) Board has elected 14 Board members on Friday (30 March) that will govern the association for next two years. Four new Board members have been elected while five previous members left the Board after serving their terms. The period April 2023 to March 2025 will see the completion of the transition to the new Board structure. The Board will meet again on Monday (24 April) to elect the Chair and other appointments. Gareth Jones, Returning Officer for the NPA Board elections, said: "The NPA has undertaken a process of significant modernisation of organisational governance over the past years. Key elements of this process include adopting modern new Articles of Association, reforming the structure of the Board and introducing term limits. The process of electing the Board has also been changed so that half of the Board will be up for election every two years - which supports continuity and reduces the risk of a loss of organisational memory." "Recognising that the Board would already be losing a lot of organisational memory in 2023 with five members of Board standing down, the Board determined that three individuals should be co-opted onto the new Board as the process of transformation continues. In March 2025, anyone that has served 12 years or more will be required to stand down."

The government has decided to refresh the NHS workforce plan, prioritising on shifting care from hospitals and into the community. The revised plan, expected to be unveiled in the summer 2025, aims to ensure the workforce is used effectively to support the delivery of the upcoming 10-Year Health Plan. Health secretary Wes Streeting explained the need to revise the plan citing Lord Darzi's report, which highlighted the dire state of the NHS, including that "too many people end up in hospital because there aren't the resources in the community to reach patients earlier." "Our 10 Year Health Plan will deliver 3 big shifts in the focus of healthcare: from hospital to community, analogue to digital, and sickness to prevention. "We will refresh the NHS workforce plan to fit the transformed health service we will build over the next decade, so the NHS has the staff it needs to treat patients on time again," Streeting said.

Chancellor of the Exchequer, Rachel Reeves, presented the Labour government 's Autumn Budget 2024 in the House of Commons on Wednesday, describing it as "a Budget to fix the foundations of the economy and deliver change by protecting working people, fixing the NHS and rebuilding Britain." The Budget, the first from a Labour government in 14 years, introduces some significant measures to boost small businesses and deliver crucial support to the NHS amid challenging economic conditions. In a move to support businesses, the government has announced a fairer business rates system by permanently lowering the business rates multipliers for retail, hospitality, and leisure (RHL) properties from 2026-27. Additionally, £1.9 billion has been allocated to support small businesses and the high street in 2025-26, including freezing the small business multiplier and providing a 40% relief on RHL property bills, up to a £110,000 cash cap. To repair the public finances and raise funding for public services, the government has decided to increase the employer National Insurance Contributions (NICs) rate by 1.2 percentage points to 15%, with effect from 6 April 2025.

In response to stakeholder feedback, the General Pharmaceutical Council (GPhC) is developing a streamlined, single route to registration that will replace the current multiple-pathway system for overseas pharmacists wishing to practice in Great Britain. This revised approach will include updated standards for the education and training of internationally qualified pharmacists, with all applicants still required to pass a registration assessment. The GPhC's Council intends to streamline the registration pathway, reducing the two-year process to one-year process. This new pathway will encompass both university study and in-practice training. Historically, pharmacists qualified within the European Economic Area (EEA) or European Free Trade Association (EFTA) have been eligible for qualification recognition in Great Britain. While this recognition has been extended until September 2028, the future requirement for EEA-qualified pharmacists to undergo the new registration route remains contingent on forthcoming government decisions. Initially, the GPhC had explored the development of three distinct registration routes for internationally-qualified pharmacists, "however decided to change this proposed approach after considering feedback from stakeholders."

The UK retail sector faced significant challenges in 2024, but 2025 is expected to be an even tougher year for retailers. Nearly 13,500 retail stores permanently shut their doors in the last 12 months -an average of 37 closures each day-according to provisional data from the Centre for Retail Research. This figure represents a notable 28.4 per cent increase from the 10,494 closures recorded in 2023, although it remains below the annual closure rates observed between 2019 and 2022. Independent retailers, typically small businesses with one to five stores, accounted for over 84 per cent of all closures during 2024. This marked a sharp 45 per cent surge in shutdowns for independents compared to the previous year when they were responsible for 74.5 per cent of closures, totalling 7,793 stores. The group's research director, Prof Joshua Bamfield told the Guardian: "The results for 2024 show that although the outcomes for store closures overall were not as poor as in either 2020 or 2022, they are still disconcerting, with worse set to come in 2025."

Community Pharmacy England (CPE) has voiced strong opposition to the Environment Agency's (EA) proposals to increase waste charges, set to be implemented in April 2025. The EA launched a consultation on these proposals from 11 November 2024 to 20 January 2025, seeking feedback on new regulatory charges for waste activities, including waste exemptions, a waste crime levy, and adjustments to hourly rates for certain activities. The agency emphasised that these charge proposals are designed to fund regulatory work targeting waste crime. In its response, CPE said that they "strongly disagree" with the proposed registration charge of £56 for waste exemptions, which would apply for a three-year period. The CPE argued that such charges would "put further pressure on a sector that is already at breaking point" and they "have no ability to pass on costs to their NHS patients." "NHS community pharmacies are experiencing significant financial pressures due to chronic government underfunding and the current economic climate," CPE stated.

NHS England has reassured that GP Additional Roles Reimbursement Scheme funding will continue in 2025/26, encouraging primary care networks (PCNs) to use it for recruiting recently qualified GPs. In October 2024, updates to the Network Contract DES specification enabled PCNs to claim reimbursement for hiring recently qualified GPs through the ARRS for the remainder of 2024/25. An additional £82 million in funding was also announced to allow PCNs to employ over 1,000 additional GPs. This action is part of the government's strategy to boost long-term GP employment, helping practices offer more appointments for patients and addressing the issue of unemployment among newly qualified GPs. However, NHS England recognised that uncertainty about the continuation of ARRS funding beyond 2024/25 has been a barrier for some PCNs in undertaking recruitment of recently qualified GPs. To address this, Dr. Amanda Doyle, national director for primary care and community services at NHSE, issued an official statement reaffirming the continuation of this funding into 2025/26.

Campaigners have submitted an open letter to the Department of Health and Social Care (DHSC), urging the Minister for Primary Care and Public Health to freeze prescription charges to keep people with long-term conditions alive and well. The campaign is led by the Prescription Charges Coalition, which represents over 50 organisations, including Royal Pharmaceutical Society (RPS) and Pharmacists' Defence Association (PDA). Currently, the prescription charge is £9.65 per item, and campaigners have asked the government to freeze it for 2024 and 2025 as people living with long-term health conditions in England are "being forced to choose between heating, eating, and taking their vital medication on a daily basis." In 2023, a study conducted by the Prescription Charges Coalition revealed that almost 10 per cent of survey participants had skipped medication in the previous year due to the cost of prescriptions. This led to increased physical and mental health problems, as well as impacted the time they took off work. Laura Cockram, Chair of the Prescription Charges Coalition and Head of Campaigns at Parkinson's UK, expressed deep concern that a further rise in the charge this year will lead to people skipping or not taking the full dose of their medication, which will affect their health and put more pressure on the already under pressure NHS.